Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:04:32 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PHAR - PHARMING GROUP NV SPON ADS EACH REP 10 ORD SHS - http://www.pharmanetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHAR - Q0.18.24·10.501.09.8003+0.20032.11.715339.53  9.94  9.5316.71  9.2716:00:00Apr 2415 min RT 2¢

Recent Trades - Last 10 of 33
Time ETExPriceChangeVolume
16:00:00Q9.61-0.841
15:59:09Q9.80-0.655
15:59:07Q9.57-0.8864
15:55:21Q9.43-1.026
15:37:21Q9.895-0.55541
15:07:51Q9.29-1.168
14:34:35Q9.80030.2003112
14:20:41Q9.90-0.5530
13:36:43Q9.35-1.101
12:26:52Q10.930.4840

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-24 01:00U:PHARNews ReleasePharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD(TM)) 2024 Rare Impact Awards
2024-04-08 01:00U:PHARNews ReleasePharming announces completion of enrollment in pediatric clinical trial of leniolisib
2024-04-03 02:00U:PHARNews ReleasePharming Group to participate in April investor conferences
2024-03-14 02:00U:PHARNews ReleasePharming Group reports fourth quarter and full year 2023 financial results
2024-02-29 02:00U:PHARNews ReleasePharming Group to report fourth quarter and full year 2023 financial results on March 14
2024-02-08 02:00U:PHARNews ReleasePharming Group to participate in February investor conferences
2024-01-08 01:00U:PHARNews ReleasePharming Group announces updated full year 2023 guidance and Joenja ‚ ® U.S. launch update
2023-12-13 01:00U:PHARNews ReleasePharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
2023-11-21 01:00U:PHARNews ReleasePharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
2023-11-01 03:00U:PHARNews ReleasePharming Group to participate in November investor conferences
2023-10-26 01:00U:PHARNews ReleasePharming Group reports third quarter 2023 financial results
2023-10-12 02:00U:PHARNews ReleasePharming Group to report third quarter 2023 financial results on October 26
2023-09-25 10:00U:PHARNews ReleasePharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
2023-08-24 02:00U:PHARNews ReleasePharming Group to participate in September investor conferences
2023-08-09 01:00U:PHARNews ReleasePharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
2023-07-18 01:00U:PHARNews ReleasePharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
2023-07-13 02:00U:PHARNews ReleasePharming Group to report second quarter and first half 2023 financial results on August 3
2023-06-01 01:00U:PHARNews ReleasePharming announces sale of priority review voucher
2023-05-25 02:00U:PHARNews ReleasePharming Group to attend the following Investor Conferences in June
2023-05-11 01:00U:PHARNews ReleasePharming Group reports financial results for the first quarter of 2023